Intellipharmaceutics International Inc. (IPCI) SEC Filing 20-F Annual report for the fiscal year ending Monday, November 30, 2015

Consolidated Balance Sheets

Consolidated Balance Sheets (parentheticals)

Consolidated Statements Of Cash Flows

Consolidated Statements Of Operations And Comprehensive Loss

Consolidated Statements Of Shareholders' Equity (deficiency)

Accounting Policies, By Policy (policies)

Document And Entity Information

Note 1 - Nature Of Operations

Note 1 - Nature Of Operations (details)

Note 10 - Capital Stock

Note 10 - Capital Stock (details)

Note 11 - Options

Note 11 - Options (details)

Note 11 - Options (details) - Components Of Stock-based Compensation Expense

Note 11 - Options (details) - Exercise Prices Of Stock Options Oustanding

Note 11 - Options (details) - Fair Value Assumptions Of Option Awards

Note 11 - Options (details) - Stock Option Transactions

Note 11 - Options (tables)

Note 12 - Deferred Share Units

Note 12 - Deferred Share Units (details)

Note 12 - Deferred Share Units (details) - Deferred Share Units

Note 12 - Deferred Share Units (tables)

Note 13 - Restricted Share Units

Note 13 - Restricted Share Units (details)

Note 14 - Warrants

Note 14 - Warrants (details)

Note 14 - Warrants (details) - Warrant Transactions

Note 14 - Warrants (details) - Warrants Outstanding And Exercisable

Note 14 - Warrants (tables)

Note 15 - Income Taxes

Note 15 - Income Taxes (details)

Note 15 - Income Taxes (details) - Deferred Tax Assets And Liabilities

Note 15 - Income Taxes (details) - Income Tax Reconciliation

Note 15 - Income Taxes (details) - Summary Of Operating Losses

Note 15 - Income Taxes (tables)

Note 16 - Contingencies

Note 16 - Contingencies (details)

Note 17 - Financial Instruments

Note 17 - Financial Instruments (details)

Note 17 - Financial Instruments (details) - Accounts Receivable Aging

Note 17 - Financial Instruments (details) - Contractual Maturities Of The Undiscounted Cash Flows Of Financial Liabilities

Note 17 - Financial Instruments (details) - Fair Value Of Financial Assets And Financial Liabilities Not Measured On A Recurring Basis

Note 17 - Financial Instruments (details) - Foreign Exchange Rates

Note 17 - Financial Instruments (details) - Reconciliation Of Level 3 Fair Value Measurements

Note 17 - Financial Instruments (tables)

Note 18 - Segmented Information

Note 18 - Segmented Information (details) - Information By Geographic Segment

Note 18 - Segmented Information (tables)

Note 2 - Basis Of Presentation

Note 3 - Significant Accounting Policies

Note 3 - Significant Accounting Policies (details)

Note 3 - Significant Accounting Policies (details) - Depreciation Rates

Note 3 - Significant Accounting Policies (tables)

Note 4 - Accounts Receivable

Note 5 - Property And Equipment

Note 5 - Property And Equipment (details)

Note 5 - Property And Equipment (details) - Property And Equipment

Note 5 - Property And Equipment (tables)

Note 6 - Accrued Liabilities

Note 6 - Accrued Liabilities (details) - Accrued Liabilities

Note 6 - Accrued Liabilities (tables)

Note 7 - Due To Related Parties

Note 7 - Due To Related Parties (details)

Note 7 - Due To Related Parties (details) - Amounts Due To Related Parties

Note 7 - Due To Related Parties (details) - Amounts Due To Related Parties (parentheticals)

Note 7 - Due To Related Parties (tables)

Note 8 - Employee Costs Payable

Note 8 - Employee Costs Payable (details)

Note 9 - Lease Obligations

Note 9 - Lease Obligations (details)

Note 9 - Lease Obligations (details) - Minimum Lease Payments

Note 9 - Lease Obligations (details) - Minimum Lease Payments (parentheticals)

Note 9 - Lease Obligations (tables)